Related Experiment Video

Updated: Aug 12, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

Cardiovascular complications in the Ehlers-Danlos syndrome with minimal external findings

I Shohet, I Rosenbaum, M Frand

    Clinical Genetics
    |March 1, 1987
    PubMed

    Insights

    Ehlers-Danlos syndrome (EDS) is a connective tissue disorder with diverse types. This report highlights a specific EDS type presenting with subtle external signs but severe vascular complications.

    Area of Science:

    • Connective tissue disorders
    • Genetics and disease mechanisms
    • Cardiovascular complications

    Background:

    • Ehlers-Danlos syndrome (EDS) is a group of inherited disorders affecting connective tissues.
    • Eleven distinct EDS types are recognized, varying in clinical presentation and severity.
    • Some EDS types are associated with significant cardiovascular issues.

    Observation:

    • This report focuses on an EDS variant with minimal external physical manifestations.
    • The primary concern in this EDS type is severe internal vascular complications.

    Findings:

    • A specific Ehlers-Danlos syndrome subtype presents with inconspicuous external features.
    • This EDS variant is characterized by serious internal vascular complications, despite minimal outward signs.

    Implications:

    • Highlights the importance of considering vascular risks in EDS patients, even with subtle external signs.
    • Emphasizes the need for early diagnosis and management of vascular complications in specific EDS types.
    • Contributes to understanding the heterogeneity of Ehlers-Danlos syndrome and its clinical spectrum.

    More Related Videos

    A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse08:19

    A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

    Published on: December 16, 2022

    Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting03:40

    Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

    Published on: January 17, 2025

    Related Concept Videos

    Assessment of the Cardiovascular System II: Inspection01:29

    Assessment of the Cardiovascular System II: Inspection

    Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
    Head and Neck
    Assessment of the Cardiovascular System III: Palpation01:27

    Assessment of the Cardiovascular System III: Palpation

    Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
    Jugular Venous Pressure (JVP) Measurement
    Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
    Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

    Cardiovascular System Abnormal Findings I: Inspection and Palpation

    In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
    Abnormal findings observed during an inspection
    Rheumatic Heart Disease I: Introduction01:23

    Rheumatic Heart Disease I: Introduction

    Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...